» Articles » PMID: 34671662

Antibacterial Properties of Canine Platelet-Rich Plasma and Other Non-Transfusional Hemo-Components: An Study

Overview
Journal Front Vet Sci
Date 2021 Oct 21
PMID 34671662
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

This study was carried out to evaluate the potential antibacterial properties of canine non-transfusional hemo-components. Therapeutic formulations commonly used for regenerative medicine purposes (platelet-rich plasma, platelet gel, platelet lysate, fibrin glue), considering both leukocyte-rich and leukocyte-poor formulations, but also platelet-poor plasma and activating substances (thrombin, calcium gluconate), were tested to detect elements with potential antimicrobial properties. The antibacterial effect was tested on different bacterial strains ( subspecies subspecies , and subspecies ) isolated from canine wounds and classified as susceptible, multidrug-, extensively, and pandrug-resistant bacteria toward a known panel of human and veterinary antibiotics. The evaluation was carried out by agar gel diffusion method (Kirby-Bauer) and micro-inhibition in broth using microplates and spectrophotometer reading. The study findings confirmed the hypothesized antibacterial properties of canine non-transfusional hemo-components. A more effective bacteriostatic effect was found against Gram-negative bacteria, drug-resistant too. The presence of leukocytes or platelets does not appear to be essential for the antibacterial effect. Further studies should be conducted to evaluate the exact mechanism of action of the antimicrobial activity. However, non-transfusional hemo-components could be a useful natural aid in controlling bacterial infections in dogs.

Citing Articles

Translational Clinical Research: Use of Allogeneic Platelet-Rich Fibrin (PRF) for Wound Regeneration in Two Small-Sized Dogs.

Soares C, Dias I, Barros L, Carvalho P, Pires M Animals (Basel). 2025; 15(3).

PMID: 39943137 PMC: 11816182. DOI: 10.3390/ani15030367.


Antibacterial Effect of Canine Leucocyte Platelet-Rich Plasma (L-PRP) and Canine Platelet-Poor Plasma (PPP) Against Methicillin-Sensitive and Methicillin-Resistant .

Perego R, Meroni G, Martino P, Spada E, Baggiani L, Proverbio D Vet Sci. 2024; 11(12).

PMID: 39729010 PMC: 11680258. DOI: 10.3390/vetsci11120670.


Growth factor and cytokine characterization of canine platelet lysate with variable leukocyte concentration, plasma content, and heat-sensitive proteins.

Lunardon T, Sumner S, Mollabashi M, Darzenta N, Davis E, Naskou M Front Vet Sci. 2024; 11:1408080.

PMID: 39071789 PMC: 11272652. DOI: 10.3389/fvets.2024.1408080.


In Vitro Antimicrobial Properties and Their Mechanisms in Relation to Reactive Oxygen Species of Canine Platelet-Rich Fibrin.

Warin R, Vongchan P, Suriyasathaporn W, Hall D, Boripun R, Suriyasathaporn W Animals (Basel). 2023; 13(24).

PMID: 38136823 PMC: 10740687. DOI: 10.3390/ani13243786.


Antimicrobial Activity of Plasma Rich in Platelets (PRP) on the Ocular Microbiota of Healthy Horses from Minas Gerais: Study.

Torres L, Florez C, Oliveira J, Vieira G, Ribeiro I, Keller K Vet Med Int. 2023; 2023:2407768.

PMID: 37622165 PMC: 10447163. DOI: 10.1155/2023/2407768.


References
1.
Saleem M, Pisani F, Zahid F, Georgakopoulos I, Pustina-Krasniqi T, Xhajanka E . Adjunctive Platelet-Rich Plasma (PRP) in Infrabony Regenerative Treatment: A Systematic Review and RCT's Meta-Analysis. Stem Cells Int. 2018; 2018:9594235. PMC: 5884028. DOI: 10.1155/2018/9594235. View

2.
Giusti I, Rughetti A, DAscenzo S, Millimaggi D, Pavan A, DellOrso L . Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009; 49(4):771-8. DOI: 10.1111/j.1537-2995.2008.02033.x. View

3.
Eberl C, Speth C, Jacobsen I, Hermann M, Hagleitner M, Deshmukh H . Candida: Platelet Interaction and Platelet Activity in vitro. J Innate Immun. 2018; 11(1):52-62. PMC: 6738150. DOI: 10.1159/000491030. View

4.
Mazzucco L, Balbo V, Guaschino R . "Reasonable compromise" to define the quality standards of platelet concentrate for non-transfusion use (CPunT). Transfus Apher Sci. 2012; 47(2):207-11. DOI: 10.1016/j.transci.2012.06.006. View

5.
Drago L, Bortolin M, Vassena C, Romano C, Taschieri S, Fabbro M . Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study. PLoS One. 2014; 9(9):e107813. PMC: 4169456. DOI: 10.1371/journal.pone.0107813. View